Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases

Akira Machida1, Takuya Ohkubo, Takanori Yokota

  • 1Department of Neurology and Neurological Science, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Insights

MicroRNAs (miRNAs) in cerebrospinal fluid (CSF) show promise as biomarkers for diagnosing brain diseases. This chapter explores their feasibility and methods for isolating these crucial regulatory RNAs from CSF.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • MicroRNAs (miRNAs) are small, noncoding regulatory RNAs.
  • They function in post-transcriptional gene expression regulation.
  • Circulating miRNAs in body fluids are emerging as disease biomarkers, particularly in oncology.

Purpose of the Study:

  • To investigate the feasibility of using cerebrospinal fluid (CSF) miRNAs as biomarkers for brain disease diagnosis.
  • To describe methods for isolating miRNAs from CSF.

Main Methods:

  • Literature review on miRNA isolation techniques from CSF.
  • Analysis of current understanding of CSF miRNA roles in brain diseases.

Main Results:

  • Limited knowledge exists regarding miRNAs specifically within CSF.
  • CSF miRNAs hold potential as diagnostic biomarkers for neurological conditions.

Conclusions:

  • Cerebrospinal fluid (CSF) miRNAs represent a promising, yet understudied, area for brain disease diagnostics.
  • Further research into CSF miRNA isolation and analysis is warranted.